SunRock Biopharma

SRB1 (hematologic tumors)

Discovery

Discovery

Preclinical

in vitro

in vivo

Regulatory

Clinical phases

Phase I

Phase II

Phase III

SRB1 (solid tumors)

Discovery

Discovery

Preclinical

in vitro

in vivo

Regulatory

Clinical phases

Phase I

Phase II

Phase III

Anti HER3-UND

Discovery

Discovery

Preclinical

in vitro

in vivo

Regulatory

Clinical phases

Phase I

Phase II

Phase III

Anti-HER3 mAb SRB17

Discovery

Discovery

Preclinical

in vitro

in vivo

Regulatory

Clinical phases

Phase I

Phase II

Phase III

Anti-HER3 – EGFR bispecific SRB19

Discovery

Discovery

Preclinical

in vitro

in vivo

Regulatory

Clinical phases

Phase I

Phase II

Phase III

Pipeline

SRB1 (hematologic tumors)

SRB1 (solid tumors)

Anti HER3-UND

Anti-HER3 mAb SRB17

Anti-HER3 – EGFR bispecific SRB19